DIA Unveils Co-Chairs of 2017 EuroMeeting in Glasgow
The Drug Information Association (DIA) has released a video to introduce the two chairpersons of its 2017 EuroMeeting, to be held in Glasgow, U.K., from March 29-31
The Drug Information Association (DIA) has released a video to introduce the two chairpersons of its 2017 EuroMeeting, to be held in Glasgow, U.K., from March 29-31.
The co-chairs of the congress are:
- Ian Hudson, M.D., who became chief executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) in September 2013. He practiced as a pediatrician, before working joining the pharmaceutical industry in clinical research and development between 1989 and 2001, after which he joined the former Medicines Control Agency as director of its licensing division. Before being appointed as chief executive of MHRA, he was the agency’s licensing director, responsible for the majority of its medicines licensing activities. He was also the U.K. delegate to the Committee for Human Medicinal Products and was its vice chairman from October 2012 to September 2013.
- Susan Forda, PhD, Vice President, International Regulatory Affairs, Eli Lilly and Company. She initially trained as a pharmacist. After completing a PhD in neuropharmacology, she worked as a post-doctoral research fellow at St George's Hospital Medical School, University of London. She joined SmithKline Beecham Pharmaceuticals as a regulatory associate in the Worldwide Regulatory Affairs Department and was the U.K. affiliate’s corporate affairs director. She is currently chair of the Scientific, Technical, Regulatory Policy Committee of the European Federation of Pharmaceutical Industries and Associations.
To watch the video, go to: http://www.diaglobal.org/en/flagship/euromeeting/about/conference
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
